Resources
Clinical Patient Forms and Sample Documents
- BMC Clinical Tools and Forms
- Recovery Behavior Worksheet
- Sample Buprenorphine Patient Log (100-275 patients)
- Sample Buprenorphine Patient Log (0-99 patients)
- Sample Home Induction Worksheet
- Provider Guide: Home Initiation for Patients Using Heroin
- Patient Guide: Buprenorphine Initiation for Heroin
Treatment Agreements
Screening and Assessment Tools
Clinical Guides and Algorithms
- MOC Drug Testing and Ordering Reference
- Naltrexone Step-by-Step
- SAMHSA Tip 63 Manual
- BMC OBAT Policy and Procedure Manual
- MAT in the ED
- Buprenorphine Induction (60 minute podcast)
- BMC Perioperative Management of Non-Pregnant Patients on Maintenance Therapy for Opioid Dependence
- Perioperative Buprenorphine Management
- MDHHS Opioid Start Talking
- Provider Protocol: Unsupervised Initiation for Fentanyl
- Patient Guide: Buprenorphine Initiation for Fentanyl
- Michigan OPEN/MEDIC Emergency Department Naloxone Implementation Guide
MOC Webinars
- Benzodiazepines
- Beyond the Waiver: Practical Tips for Buprenorphine Prescibers
- OUD and Pregnancy
- Addiction Treatment for Patients with Endocarditis
- Methamphetamine: New Risks, Current Treatments
- Neurobiology of Addiction
- Substance Use Disorder in Rural Communities
- Buprenorphine Management in Pain Patients
- Drug Screening
- Introduction to Adolescent Substance Use
- Motivational Interviewing and Opioid Use for Prescribers
- Gabapentinoids
- Treatment Gaps for Patients Taking Opioids for Chronic Pain
- Telemedicine Delivery of Substance Use Disorder Treatment
- Drug Legalization in the U.S.
- Marijuana Related Healthcare Utilization and Legalization
Chronic Pain Resources
Waiver Training and Support
Hepatitis C Resources
Hepatitis C Provider Resources
- HCV Case Reporting Form
- HCV Consulting Agreement Template
- HCV CPT Codes
- Hepatitis C Education
- Liverpool HCV Drug Interaction checker
- AASLD/IDSA HCV guidelines
- MDHHS Viral Hepatitis and Liver Cancer
- MDHHS Viral Hepatitis Unit Annual Report
- MDHHS HCV Elimination Announcement
- HHS Viral Hepatitis site
- HHS Viral Hepatitis National Strategic Plan: A Roadmap to Elimination in the United States 2021-2025
- CDC Guidelines on HCV Screening
- Fibrosis-4 (FIB-4) Calculator
Hepatitis C Patient Resources
Research Articles and Books
- Next Stage in Burprenorphine Treatment (Addresses misconceptions about MAT)
- Interpreting Urine Drug Screen (UDS)
- Treating Opioid Addiction
- Monitoring Liver Function Tests in Patients Receiving Naltrexone or Extended Release Naltrexone
Counseling
Diversion
- A Review of Buprenorphine Diversion and Misuse: The Current Evidence Base and Experiences From Around the World
- Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience
- Diversion of Methadone and Buprenorphine from Opioid Substitution Treatment: Patients who Regularly Sell or Share Their Medication
- Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma
- Perceptions and practices addressing diversion among US buprenorphine prescribers
- The relationship between diversion-related attitudes and sharing and selling buprenorphine
Emergency Department
- Cost Effectiveness of Emergency Department-Initiated Treatment for Opioid Dependence
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence
- Emergency department-based peer support for opioid use disorder: Emergent functions and forms
- Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention
- Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program
- One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose
Finance
- A Financial Model for Team-Based Opioid Use Disorder Treatment
- INTEGRATING BEHAVIORAL HEALTH AND PRIMARY CARE: REIMBURSEMENT CONSIDERATIONS AND TIPS
Hospital
- Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical Trial
- Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder
Length of Treatment
MAT/MOUD Effectiveness
- Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Review)
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009
- Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids
Polysubstance
Pregnancy
- Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
- Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations
- Simultaneous quantification of buprenorphine, naloxone and phase Iand II metabolites in plasma and breastmilk by liquid chromatography–tandem mass spectrometry
Primary Care
- Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study
- A buprenorphine education and training program for primary care residents: Implementation and evaluation
- Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine
- Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
- Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers
Stigma
- Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms
- Does Out Choice of Substance-Related Terms Influence Perceptions of Treatment Need? An Empirical Investigation with Two Commonly Used Terms
- Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation
- Caring for Ms. L. — Overcoming My Fear of Treating Opioid Use Disorder
- Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Other Substance Use Educational Resources and Websites
- American Society of Addiction Medicine (ASAM)
- Boston Medical Center (BMC) Office Based Addiction Treatment (OBAT)
- Provider Clinical Support System (PCSS)
- American Association for the Treatment of Opioid Dependence, Inc. (AATOD)
- Harm Reduction Approach to Treatment of All Substance Use Disorders
- Prescribe to Prevent (Naloxone)
- Providers Clinical Support System (PCSS) Education & Training
- Providers Clinical Support System (PCSS) Webinars
- Providers Clinical Support System (PCSS) Substance Use Disorder 101
- American Society of Addiction Medicine (ASAM) Webinars
- UCSF Addiction Psychiatry Bootcamp
- Podcast- Core IM- #49 Smoking Cessation
- Podcast- Core IM- #19 Unhealthy Alcohol Use
- Podcast- Core IM- #27 Treatment for Alcohol Use Disorder
- Intersection of Pain and Addiction